| Literature DB >> 16242021 |
Jerzy E Tyczynski1, Hans J Berkel.
Abstract
BACKGROUND: There were significant changes in cancer mortality in the USA over the last several decades, in the whole country and in particular states. However, no in depth analysis has been published so far, dealing with changes in mortality time trends in the state of Ohio. Since the state of Ohio belongs to the states of relatively high level of all-sites mortality in both males and females, it is of interest to analyze recent changes in mortality rates, as well as to compare them with the situation in the rest of the USA. The main aim of this study was to analyze, describe and interpret all-sites cancer mortality time trends in the population of the State of Ohio.Entities:
Mesh:
Year: 2005 PMID: 16242021 PMCID: PMC1277822 DOI: 10.1186/1471-2407-5-136
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Figure 1Cancer mortality in the USA, 1997–2001, by state, gender and race # – Age-adjusted mortality rates (World Standard Population).
All-sites cancer mortality time trends, 1970–2001, Ohio and USA, by gender, age and race
| | |||||||||||
| | |||||||||||
| | |||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | |||||||||||
| | |||||||||||
| | |||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | |||||||||||
| | |||||||||||
| | |||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | |||||||||||
| | |||||||||||
| | |||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | |||||||||||
| | |||||||||||
| | |||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | |||||||||||
| | |||||||||||
| | |||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | |||||||||||
| | |||||||||||
| | |||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | |||||||||||
| | |||||||||||
| | |||||||||||
| | - | ||||||||||
| | - | ||||||||||
| | - | ||||||||||
(a) – p < 0.05
# – EAPC – Estimated Annual Percentage Change, ## – Age-adjusted standardized rate (World standard population)
Cancer mortality in Ohio, 1997–2001, by gender and race
| Lung | 52.3 | 18,996 | 33.4 | Lung | 70.9 | 2,306 | 32.7 |
| Colon and Rectum | 15.4 | 5,897 | 10.4 | Prostate | 31.1 | 1,130 | 16.0 |
| Prostate | 12.4 | 5,628 | 9.9 | Colon and Rectum | 21.0 | 705 | 10.0 |
| Non-Hodgkin Lymphoma | 7.0 | 2,642 | 4.6 | Pancreas | 10.0 | 328 | 4.6 |
| Pancreas | 7.0 | 2,569 | 4.5 | Esophagus | 7.7 | 233 | 3.3 |
| Leukemia | 6.3 | 2,302 | 4.0 | Stomach | 6.8 | 230 | 3.3 |
| Esophagus | 5.4 | 1,913 | 3.4 | Liver | 6.8 | 218 | 3.1 |
| Urinary Bladder | 4.4 | 1,810 | 3.2 | Leukemia | 6.1 | 203 | 2.9 |
| Kidney | 4.2 | 1,495 | 2.6 | Myeloma | 5.9 | 199 | 2.8 |
| Brain | 4.4 | 1,395 | 2.5 | Non-Hodgkin Lymphoma | 5.0 | 168 | 2.4 |
| Lung | 28.1 | 13,274 | 24.6 | Lung | 33.3 | 1,524 | 24.1 |
| Breast | 18.2 | 8,520 | 15.8 | Breast | 25.3 | 1,134 | 17.9 |
| Colon and Rectum | 10.7 | 6,236 | 11.5 | Colon and Rectum | 14.5 | 759 | 12.0 |
| Ovary | 5.8 | 2,747 | 5.1 | Pancreas | 7.8 | 401 | 6.3 |
| Pancreas | 4.8 | 2,706 | 5.0 | Ovary | 4.0 | 195 | 3.1 |
| Non-Hodgkin Lymphoma | 4.5 | 2,541 | 4.7 | Myeloma | 3.6 | 191 | 3.0 |
| Leukemia | 3.7 | 1,977 | 3.7 | Corpus and Uterus, NOS | 3.7 | 179 | 2.8 |
| Corpus and Uterus, NOS | 2.7 | 1,379 | 2.6 | Leukemia | 3.8 | 178 | 2.8 |
| Brain | 2.8 | 1,093 | 2.0 | Stomach | 3.0 | 173 | 2.7 |
| Kidney | 2.0 | 1,008 | 1.9 | Cervix Uteri | 3.2 | 152 | 2.4 |
# – Age-adjusted mortality rate (World Standard Population)
Figure 2Cancer mortality time trends, all sites, Ohio, 1970–2001, by race # – Age-adjusted mortality rates (World Standard Population).
Figure 3Cancer mortality time trends, all sites, Ohio vs USA, 1970–2001, by race # – Age-adjusted mortality rates (World Standard Population).